Key Data Files for this Active Pharmaceutical Ingredient:

Drug Master Files, 21 CFR, and other industry portals Patent/Exclusivity data file Drug Approval Drug Safety Freedom of Information Federal Register pages Pharma Companies Pharmacopeial Information Preferred API Supplier (Clients Only)

FDA Approval Activities for this Drug… Norvir (Ritonavir) Capsules & Solution, Abbott 20-659/S-030 & 20-945/S-013 9/10/03 9/25/03 9/25/03 Norvir (Ritonavir) Abbott 20-659/S-027 & 20-945/S-008 3/14/02 3/29/02 3/14/02 Norvir (Ritonavir) Abbott 20-659/S-026 & 20-945/S-007 3/6/01 4/26/01 Norvir (ritonavir capsules) Soft Gelatin (ritonavir), Abbott 20-659/S-025 20-945/S-005 08/21/01 4/25/03 Norvir (Ritonavir) Abbott 20-650/S-013 & 20-680/S-011 5/26/99 Norvir Indications:Protease inhibitor that is indicated, in combination with other antiretroviral agents, for the treatment of HIV-1 infection. Norvir (Ritonavir) Abbott 20-945 6/29/99 Norvir Indications: A protease inhibitor that is indicated, in combination with other antiretroviral agents, for the treatment of HIV-1 infection. Kaletra (lopinavir/ritonavir) Abbott Laboratories   For the latest approval information, locate this drug using this index.